# Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis

> **NCT05962788** · PHASE3 · TERMINATED · sponsor: **Aurinia Pharmaceuticals Inc.** · enrollment: 4 (actual)

## Conditions studied

- Adolescent Lupus Nephritis
- Pediatric Lupus Nephritis

## Interventions

- **DRUG:** voclosporin

## Key facts

- **NCT ID:** NCT05962788
- **Lead sponsor:** Aurinia Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-03-28
- **Primary completion:** 2025-07-04
- **Final completion:** 2025-07-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** DSMB recommendation
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962788, "Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT05962788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*